Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

ClinicalTrials.gov ID: NCT01637961

Public ClinicalTrials.gov record NCT01637961. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Evaluation of MLN8237 (NSC# 747888) in the Treatment of Recurrent or Persistent Leiomyosarcoma of the Uterus

Study identification

NCT ID
NCT01637961
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Cancer Institute (NCI)
NIH
Enrollment
23 participants

Conditions and interventions

Interventions

  • Alisertib Drug
  • Laboratory Biomarker Analysis Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2012
Primary completion
Jul 31, 2014
Completion
Feb 10, 2017
Last update posted
Jul 22, 2019

2012 – 2017

United States locations

U.S. sites
50
U.S. states
19
U.S. cities
40
Facility City State ZIP Site status
Hartford Hospital Hartford Connecticut 06102
Smilow Cancer Hospital Care Center at Saint Francis Hartford Connecticut 06105
The Hospital of Central Connecticut New Britain Connecticut 06050
Florida Hospital Orlando Orlando Florida 32803
University of Hawaii Cancer Center Honolulu Hawaii 96813
Saint Alphonsus Cancer Care Center-Boise Boise Idaho 83706
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Sudarshan K Sharma MD Limted-Gynecologic Oncology Hinsdale Illinois 60521
Indiana University/Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202
Saint Vincent Hospital and Health Care Center Indianapolis Indiana 46260
McFarland Clinic PC-William R Bliss Cancer Center Ames Iowa 50010
Iowa Methodist Medical Center Des Moines Iowa 50309
Iowa-Wide Oncology Research Coalition NCORP Des Moines Iowa 50309
Medical Oncology and Hematology Associates-Des Moines Des Moines Iowa 50309
Medical Oncology and Hematology Associates-Laurel Des Moines Iowa 50314
Mercy Medical Center - Des Moines Des Moines Iowa 50314
Iowa Lutheran Hospital Des Moines Iowa 50316
University of Iowa/Holden Comprehensive Cancer Center Iowa City Iowa 52242
Saint Joseph Mercy Hospital Ann Arbor Michigan 48106-0995
Michigan Cancer Research Consortium NCORP Ann Arbor Michigan 48106
Beaumont Hospital-Dearborn Dearborn Michigan 48124
Saint John Hospital and Medical Center Detroit Michigan 48236
Hurley Medical Center Flint Michigan 48502
Genesys Regional Medical Center Grand Blanc Michigan 48439
Allegiance Health Jackson Michigan 49201
Sparrow Hospital Lansing Michigan 48912
Saint Mary Mercy Hospital Livonia Michigan 48154
Saint Joseph Mercy Oakland Pontiac Michigan 48341
Lake Huron Medical Center Port Huron Michigan 48060
Saint Mary's of Michigan Saginaw Michigan 48601
University of Mississippi Medical Center Jackson Mississippi 39216
Cancer Research for the Ozarks NCORP Springfield Missouri 65804
Mercy Hospital Springfield Springfield Missouri 65804
CoxHealth South Hospital Springfield Missouri 65807
Washington University School of Medicine St Louis Missouri 63110
Nebraska Methodist Hospital Omaha Nebraska 68114
Memorial Sloan-Kettering Cancer Center New York New York 10065
UNC Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599
Carolinas Medical Center/Levine Cancer Institute Charlotte North Carolina 28203
Southeast Clinical Oncology Research (SCOR) Consortium NCORP Winston-Salem North Carolina 27104
Case Western Reserve University Cleveland Ohio 44106
Riverside Methodist Hospital Columbus Ohio 43214
Lake University Ireland Cancer Center Mentor Ohio 44060
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104
Oklahoma Cancer Specialists and Research Institute-Tulsa Tulsa Oklahoma 74146
Abington Memorial Hospital Abington Pennsylvania 19001
Reading Hospital West Reading Pennsylvania 19611
Women and Infants Hospital Providence Rhode Island 02905
AnMed Health Cancer Center Anderson South Carolina 29621
Memorial Hermann Texas Medical Center Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01637961, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 22, 2019 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01637961 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →